Praxis Precision Medicines, Inc.PRAXNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1349.13% | -100.00% | -100.00% | -100.00% | -100.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +120.51% | +51.43% | +14.08% | +16.38% | +12.64% |
| Weighted Average Shares Diluted Growth | +120.51% | +51.43% | +14.08% | +16.38% | +12.64% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +449.31% | +91.18% | +2.67% | -4.77% | +94.14% |
| Book Value per Share Growth | +189.95% | +26.28% | -15.45% | -22.87% | +75.02% |
| Debt Growth | -45.13% | -52.07% | -61.20% | -73.73% | -91.96% |
| R&D Expense Growth | +206.11% | +125.34% | +131.13% | +57.10% | +37.70% |
| SG&A Expenses Growth | +52.33% | -9.20% | +23.39% | -17.66% | +29.13% |